ALK c.3331G>A ;(p.V1111M)

Variant ID: 2-29446236-C-T

NM_004304.4(ALK):c.3331G>A;(p.V1111M)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analyses.

Cancer Medicine
Boyle, Theresa A TA; Quinn, Gwendolyn P GP; Schabath, Matthew B MB; Muñoz-Antonia, Teresita T; Saller, James J JJ; Duarte, Luisa F LF; Hair, Laura S LS; Teer, Jamie K JK; Chiang, Derek Y DY; Leary, Rebecca R; Wong, Connie C CC; Savchenko, Alexander A; Singh, Angad P AP; Charette, LaSalette L; Mendell, Kate K; Gorgun, Gullu G; Antonia, Scott J SJ; Chiappori, Alberto A AA; Creelan, Benjamin C BC; Gray, Jhanelle E JE; Haura, Eric B EB
Publication Date: 2020-01

Variant appearance in text: ALK: V1111M
PubMed Link: 31747139
Variant Present in the following documents:
  • CAM4-9-225-s002.pdf
View BVdb publication page



Structure and energy based quantitative missense variant effect analysis provides insights into drug resistance mechanisms of anaplastic lymphoma kinase mutations.

Scientific Reports
Li, Jianzong J; Huang, Yue Y; Wu, Miaomiao M; Wu, Chuanfang C; Li, Xin X; Bao, Jinku J
Publication Date: 2018-07-13

Variant appearance in text: ALK: V1111M
PubMed Link: 30006516
Variant Present in the following documents:
  • 41598_2018_28752_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page